2nd Quarter - Amendment
HOOPER, LUNDY & BOOKMAN, P.C. for ROCHE DIAGNOSTICS CORPORATION
Income
$50,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Jul 19, 2019 | $30,000 | Replaced |
| 2nd Quarter - Amendment (this page) | Oct 20, 2019 | $50,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2018 Discussion draft; Laboratory Access for Beneficiaries Act, H.R. 3584
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA LAYMAN | SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996) |
Medical/Disease Research/Clinical Labs MED
The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2018 Discussion draft; Laboratory Access for Beneficiaries Act, H.R. 3584.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA LAYMAN | SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.